Autopsy report · NCT01316939
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
Cause of deathFutility
“This study was terminated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 2 years 5 months before it stopped.
- 229 participants enrolled.
- Results were posted on the registry 3 years 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- GlaxoSmithKline
- Sponsor type
- Industry
- Conditions
- Crohn's Disease
- Interventions
- GSK1605786A; Placebo; GSK1605786A
- Participants
- 229
- Sites
- 256
- Countries
- Australia, Austria, Belgium, Bulgaria, Canada, Chile, Czechia, Denmark, Estonia, France, Germany, Hong Kong and more
Trials that died the same way
- A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough
“Study terminated due to lack of efficacy of GSK2798745 in chronic cough.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.